DualityBio Inc.
9606 · HKEX
Public Market Listing
Live quotes, historical charts, and market capitalization for DualityBio Inc. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(5 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | B7-H3Antibody–drug conjugate | Non-Small Cell Lung CancerMetastatic Castration-Resistant Prostate Cancer | |
| Phase 3 | HER2Antibody–drug conjugate | Breast CancerEndometrial Cancer HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer | |
| Phase 2 | TROP2Antibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Phase 1/2 | EGFR / HER3 (ERBB3) dualAntibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Phase 1/2 | HER3Antibody–drug conjugate | Non-Small Cell Lung Cancer |
Upcoming events
(11 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2027 (5)
August 2027 (2)
2028 (2)
2029 (1)
August 2029 (1)
What to watch
2030 (2)
2031 (1)
February 2031 (1)
What to watch
Regulatory and conference events
(2)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
Financial reports
No financial reports recorded.